|
CAPZA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.47729622873771E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28990000014539E-07 |
| Normal-vs-Stage2 |
1.222060E-03 |
| Normal-vs-Stage3 |
2.96089999995974E-06 |
| Normal-vs-Stage4 |
4.68059999980674E-07 |
| Stage1-vs-Stage2 |
1.096650E-01 |
| Stage1-vs-Stage3 |
4.439900E-03 |
| Stage1-vs-Stage4 |
8.947900E-02 |
| Stage2-vs-Stage3 |
9.190800E-01 |
| Stage2-vs-Stage4 |
9.139000E-01 |
| Stage3-vs-Stage4 |
8.343800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0051995053858E-10 |
| Normal-vs-AfricanAmerican |
4.64889999995943E-06 |
| Normal-vs-Asian |
4.938200E-02 |
| Caucasian-vs-AfricanAmerican |
9.292800E-01 |
| Caucasian-vs-Asian |
6.724200E-02 |
| AfricanAmerican-vs-Asian |
1.499040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.89379980983529E-10 |
| Normal-vs-Female |
2.75389999693232E-08 |
| Male-vs-Female |
1.138170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63148999999807E-05 |
| Normal-vs-Extreme_Weight |
7.03339999574837E-08 |
| Normal-vs-Obese |
2.02670000004623E-06 |
| Normal-vs-Extreme_Obese |
5.184500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.350000E-01 |
| Normal_Weight-vs-Obese |
5.167400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.161200E-01 |
| Extreme_Weight-vs-Obese |
3.580400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.826800E-01 |
| Obese-vs-Extreme_Obese |
6.094800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.791800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.41824354879827E-12 |
| Normal-vs-Age(61-80Yrs) |
1.88909999976339E-07 |
| Normal-vs-Age(81-100Yrs) |
8.201900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.007200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.214200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.193800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.227500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.674500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.019600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.17590003979285E-10 |
| Normal-VS-Type2 PRCC |
2.03559999999436E-05 |
| Normal-VS-KIRP CIMP |
5.00349761622942E-11 |
| Normal-VS-Unclassified PRCC |
2.72670000001085E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.258600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.817200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.378980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.661000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.236800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.186200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.16829999972235E-07 |
| Normal-vs-N1 |
8.51979999993979E-07 |
| Normal-vs-N2 |
1.712600E-01 |
| N0-vs-N1 |
3.716300E-03 |
| N0-vs-N2 |
3.241000E-01 |
| N1-vs-N2 |
5.152000E-01 |
|
|
